Single Gene Sequencing tests in Dubai & UAE

Compare available Single Gene Sequencing tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

297

Listed price range

2,800.00–4,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene Sequencing test prices

Showing 166–180 of 297 matching tests.

Single Gene Sequencing diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2223 MED13L Gene NGS Test (Transposition of the Great Arteries, Dextro‑looped Type 1) This test evaluates the MED13L gene for pathogenic variants associated with transposition of the great arteries (dextro-looped type 1). It identifies single nucleotide variants (SN...	Peripheral whole blood (3 mL EDTA) or dried blood spot on FTA card	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MED13L gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation [] Indications ["Suspected transposition of the great arteries (dextro-looped type 1)", "Congenital heart defect diagnosis confirmation", "Family recurrence risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 89848-3 ICD-10: Q20.3 Clinical summary This test evaluates the MED13L gene for pathogenic variants associated with transposition of the great arteries (dextro-looped type 1). It identifies single nucleotide variants (SNVs), insertions/deletions (indels), and copy number variations (CNVs) within the gene.
TEST-2966 MEIS2 Gene Cleft Palate, Cardiac Defects, and Mental Retardation Genetic Test This test evaluates the entire MEIS2 gene for pathogenic variants associated with cleft palate, congenital heart defects, and intellectual disability.	Peripheral Blood, Extracted DNA, or FTA Card (Dried Blood Spot)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MEIS2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Clinical suspicion of MEIS2-related syndrome", "Patients with cleft palate, cardiac defects, and intellectual disability"] Measurement technique Confirm with laboratory Codes LOINC: 81264-1 ICD-10: Q87.8, Q35.9, Q24.9, F70.9 Clinical summary This test evaluates the entire MEIS2 gene for pathogenic variants associated with cleft palate, congenital heart defects, and intellectual disability.
TEST-4899 MID2 Gene X‑Linked Intellectual Disability Type 101 Test This diagnostic test evaluates the MID2 gene for pathogenic variants associated with X-linked intellectual disability type 101.	Peripheral Whole Blood / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MID2 gene", "Single-nucleotide variants", "Small insertions and deletions"] Parameters [] Preparation [] Indications ["Diagnosis of X-linked intellectual disability type 101", "Carrier screening for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 51966-0 ICD-10: F70 Clinical summary This diagnostic test evaluates the MID2 gene for pathogenic variants associated with X-linked intellectual disability type 101.
TEST-5993 MMAA Gene Methylmalonic Aciduria, CblA Type Test This test identifies pathogenic variants in the MMAA gene associated with CblA-type methylmalonic aciduria.	Whole Blood (Peripheral), Extracted DNA, or FTA Card (Dried Blood Spot)	21–28 calendar days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MMAA gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Completed clinical history form"] Indications ["Suspected CblA-type methylmalonic aciduria", "Symptomatic patients (neonates to adults)", "Asymptomatic siblings of confirmed cases", "Couples with known carrier status", "Abnormal newborn screening results"] Measurement technique Confirm with laboratory Codes LOINC: 81642-5 ICD-10: E71.111, Z14.01, Z13.228 Clinical summary This test identifies pathogenic variants in the MMAA gene associated with CblA-type methylmalonic aciduria.
TEST-4789 MMP2 Gene Multicentric Osteolysis, Nodulosis, and Arthropathy Genetic Test This genetic test evaluates the MMP2 gene for pathogenic variants associated with Multicentric Osteolysis, Nodulosis, and Arthropathy (MONA) syndrome.	Peripheral blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MMP2 gene", "Full coding region and flanking intronic sequences"] Parameters [] Preparation ["Provide clinical history and family pedigree", "Complete a genetic counselling session prior to testing"] Indications ["Clinical suspicion of MONA syndrome", "Family history of MONA syndrome", "Need for genetic confirmation for management and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: M89.50 Clinical summary This genetic test evaluates the MMP2 gene for pathogenic variants associated with Multicentric Osteolysis, Nodulosis, and Arthropathy (MONA) syndrome.
TEST-2121 MSH6 Gene Colorectal Cancer, Hereditary Nonpolyposis Type 5 Genetic Test This genetic test evaluates the MSH6 gene for mutations associated with an increased risk of Lynch syndrome and related cancers.	Peripheral whole blood (EDTA) or buccal swab	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the MSH6 gene", "Single nucleotide variants", "Small insertions/deletions", "Copy number changes"] Parameters [] Preparation ["No specific fasting required.", "No medication or diet restrictions."] Indications ["Individuals with a family history of colorectal or endometrial cancer diagnosed before age 50.", "Individuals diagnosed with colorectal cancer before age 50.", "Individuals with first-degree relatives diagnosed with Lynch-associated cancers."] Measurement technique Confirm with laboratory Codes LOINC: 38071-4 ICD-10: Z15.09 Clinical summary This genetic test evaluates the MSH6 gene for mutations associated with an increased risk of Lynch syndrome and related cancers.
TEST-2485 MSX1 Gene Orofacial Cleft Type 5 Genetic Test This genetic test evaluates the MSX1 gene for pathogenic variants associated with orofacial cleft type 5.	Whole Blood (2-3 mL EDTA) or DNA FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MSX1 gene"] Parameters [] Preparation [] Indications ["Diagnosis of orofacial cleft type 5", "Recurrence risk assessment", "Personalized management"] Measurement technique Confirm with laboratory Codes LOINC: 94709-5 ICD-10: Q37.5, Q37.9 Clinical summary This genetic test evaluates the MSX1 gene for pathogenic variants associated with orofacial cleft type 5.
TEST-4234 MT-ATP8 Genetic Test for Infantile Hypertrophic Cardiomyopathy This test identifies pathogenic variants in the MT-ATP8 gene associated with infantile hypertrophic cardiomyopathy.	Peripheral Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MT-ATP8 gene"] Parameters [] Preparation ["No fasting or special preparation required"] Indications ["Diagnosis of infantile hypertrophic cardiomyopathy", "Prognosis assessment", "Family screening"] Measurement technique Confirm with laboratory Codes LOINC: 81304-3 ICD-10: I42.2 Clinical summary This test identifies pathogenic variants in the MT-ATP8 gene associated with infantile hypertrophic cardiomyopathy.
TEST-5380 MYBPC1 Gene Sequencing for Distal Arthrogryposis Type 1B (NGS) Test This test identifies pathogenic variants in the MYBPC1 gene associated with distal arthrogryposis type 1B.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MYBPC1 gene", "Copy number variants (CNVs) via NGS with MLPA confirmation"] Parameters [] Preparation ["Physician referral required", "Pre-test genetic counseling required"] Indications ["Individuals with suspected distal arthrogryposis type 1B", "Family members of individuals with DA1B"] Measurement technique Confirm with laboratory Codes LOINC: 51969-3 ICD-10: Q68.8, Z13.79, Z15.89 Clinical summary This test identifies pathogenic variants in the MYBPC1 gene associated with distal arthrogryposis type 1B.
TEST-4632 MYH2 Gene Inclusion Body Myopathy Genetic Test This test evaluates the MYH2 gene for pathogenic variants associated with inclusion body myopathy.	Peripheral whole blood (EDTA tube), FTA card, or extracted DNA	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH2 gene", "Single nucleotide variants", "Small indels", "Copy number changes"] Parameters [] Preparation ["No fasting required"] Indications ["Suspected hereditary inclusion body myopathy", "Diagnostic confirmation", "Family screening", "Genetic counseling"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G71.2 Clinical summary This test evaluates the MYH2 gene for pathogenic variants associated with inclusion body myopathy.
TEST-2478 NAA10 Gene (Ogden Syndrome) Genetic Test This test evaluates the NAA10 gene for pathogenic variants associated with Ogden syndrome.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NAA10 gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation ["Genetic Counselling & Pedigree Charting before sample collection", "Do not discontinue prescribed medication without consultation"] Indications ["Clinical suspicion of Ogden syndrome", "Family history of Ogden syndrome", "Presence of characteristic clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q87.8 Clinical summary This test evaluates the NAA10 gene for pathogenic variants associated with Ogden syndrome.
TEST-2503 NBN Gene (Nijmegen Breakage Syndrome) Genetic Test This test evaluates the NBN gene for pathogenic variants associated with Nijmegen breakage syndrome.	Whole Blood (EDTA), Extracted DNA, or FTA Card Dried Blood Spot	14–21 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NBN gene", "Coding region and splice sites of the NBN gene"] Parameters [] Preparation ["No specific fasting required", "Inform the lab of any recent blood transfusions or bone marrow transplants"] Indications ["Clinical suspicion of Nijmegen breakage syndrome", "Family history of NBS", "Carrier screening", "Pre-implantation genetic diagnosis (PGD)"] Measurement technique Confirm with laboratory Codes LOINC: 69079-5 ICD-10: Q87.8 Clinical summary This test evaluates the NBN gene for pathogenic variants associated with Nijmegen breakage syndrome.
TEST-4712 NDUFA2 Gene Leigh Syndrome Genetic Test This test analyzes the NDUFA2 gene for pathogenic variants associated with Leigh syndrome, a mitochondrial neurodegenerative disorder.	Peripheral Whole Blood (EDTA tube, 3–5 mL)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFA2 gene", "Coding exons and splice sites of the NDUFA2 gene"] Parameters [{"name": "NDUFA2 Gene Sequencing", "reference_range": "No pathogenic variants detected"}] Preparation ["No specific fasting required", "Inform the lab of any medications being taken"] Indications ["Suspected Leigh syndrome based on clinical presentation", "Family history of mitochondrial disorders", "Need for definitive molecular diagnosis for management and counselling"] Measurement technique Confirm with laboratory Codes LOINC: 91247-9 ICD-10: G31.82, Z13.89 Clinical summary This test analyzes the NDUFA2 gene for pathogenic variants associated with Leigh syndrome, a mitochondrial neurodegenerative disorder.
TEST-4628 NDUFA9 Gene Leigh Syndrome Genetic Test This test evaluates the NDUFA9 gene for pathogenic variants associated with Leigh syndrome.	Whole Blood, Extracted DNA, FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NDUFA9 gene", "Single nucleotide variants", "Insertions", "Deletions", "Splice-site alterations"] Parameters [] Preparation [] Indications ["Suspected Leigh syndrome", "Family history of Leigh syndrome", "Need for molecular confirmation of genetic susceptibility"] Measurement technique Confirm with laboratory Codes LOINC: 91854-7 ICD-10: G31.82 Clinical summary This test evaluates the NDUFA9 gene for pathogenic variants associated with Leigh syndrome.
TEST-6242 NEUROG3 Gene Genetic Test for Congenital Diarrhea Type 4 (Malabsorptive) This genetic test identifies pathogenic variants in the NEUROG3 gene associated with congenital malabsorptive diarrhea type 4.	Whole Blood, FTA Card, or Extracted DNA	3 - 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the NEUROG3 gene"] Parameters [] Preparation ["Genetic counselling is mandatory before sample collection", "Review of pedigree chart is required", "Inform genetic counsellor about all medications and supplements"] Indications ["Infants or children with congenital, intractable, malabsorptive diarrhea of unknown cause", "Patients requiring parenteral nutrition", "Families with a history of neonatal diarrheal disorders"] Measurement technique Confirm with laboratory Codes LOINC: 53385-3 ICD-10: P78.2, Q43.8, Z13.79 Clinical summary This genetic test identifies pathogenic variants in the NEUROG3 gene associated with congenital malabsorptive diarrhea type 4.

Category overview

Single Gene Sequencing: overview

Achieving a definitive diagnosis for a monogenic disorder often requires reading the entire genetic code of a specific gene to find elusive errors. As an elite subspecialty within our Genetics department, Single Gene Sequencing expansively scans the entirety of a single targeted gene to uncover rare or novel mutations. Utilizing state-of-the-art diagnostic technology, this comprehensive molecular screening provides the critical clarity needed to establish a firm diagnosis, safely guiding customized medical management and targeted therapeutic interventions. Consistently ranked among the top diagnostic labs in the UAE, DNA Labs guarantees the utmost in patient confidentiality, uncompromising analytical accuracy, and prompt, reliable reporting. Find the clear, definitive answers you need—schedule your single gene sequencing testing in UAE, arrange a comfortable home sample collection, or contact our specialized medical genetics professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.